{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:45:08Z","timestamp":1774122308939,"version":"3.50.1"},"reference-count":31,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2010,2,8]],"date-time":"2010-02-08T00:00:00Z","timestamp":1265587200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Paediatrica"],"published-print":{"date-parts":[[2010,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Aim:\u2002<\/jats:bold> Little is known about pyridoxine nutriture of children treated with isoniazid (INH) regimens. This study documents plasma pyridoxal 5\u2032\u2010phosphate (PLP) concentrations in children, HIV\u2010infected and HIV\u2010uninfected, receiving INH regimens.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Children from the Western Cape of South Africa hospitalized for tuberculosis (TB) management were studied. Plasma PLP concentrations were determined on enrolment, 1\u2010month after commencing TB treatment, and again after 4\u2010month\u2019s treatment. The children received a supplement meeting pyridoxine requirements.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Nineteen HIV\u2010infected and 33 HIV\u2010uninfected children received INH (dosage range 4\u201320\u2003mg\/kg) daily. Mean PLP plasma concentrations on enrolment were 8.32 (SD 6.75) ng\/mL and 11.28 (SD 3.02) ng\/mL in HIV\u2010infected and HIV\u2010uninfected children, respectively (p\u2003=\u20030.11) and after 4\u2010month\u2019s treatment 6.75 (SD 2.71) ng\/mL and 14.76 (SD 7.96) ng\/mL (p\u2003&lt;\u20030.001). On enrolment 9 (50%) HIV\u2010infected and 5 (15%) HIV\u2010uninfected children (p\u2003=\u20030.016) had suboptimal PLP concentrations (&lt;6\u2003ng\/mL); after 4\u2010month\u2019s treatment 8 (42%) and 2 (6%) (p\u2003=\u20030.004).<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> Plasma PLP concentrations in children treated for TB were low on enrolment in HIV\u2010infected and HIV\u2010uninfected children; after 4\u2010month\u2019s treatment low values were still common in HIV\u2010infected children. Additional pyridoxine supplementation of malnourished children treated for tuberculosis is advisable, particularly those HIV\u2010infected.<\/jats:p>","DOI":"10.1111\/j.1651-2227.2010.01696.x","type":"journal-article","created":{"date-parts":[[2010,2,8]],"date-time":"2010-02-08T09:28:20Z","timestamp":1265621300000},"page":"705-710","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Pyridoxal\u20105\u2010phosphate plasma concentrations in children receiving tuberculosis chemotherapy including isoniazid"],"prefix":"10.1111","volume":"99","author":[{"given":"K","family":"Cilliers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Labadarios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HS","family":"Schaaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Willemse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JS","family":"Maritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CJ","family":"Werely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Hussey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PR","family":"Donald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,3,29]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"207","volume-title":"Present knowledge in nutrition","author":"McCormick DB","year":"2001"},{"key":"e_1_2_6_3_2","first-page":"1122","article-title":"Association of vitamin B6 status with parameters of immune function in early HIV\u20101 infection","volume":"4","author":"Baum MK","year":"1991","journal-title":"J Acquire Immune Def Syndr"},{"key":"e_1_2_6_4_2","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/ajcn\/46.4.659","article-title":"Pyridoxine supplementation: effect on lymphocyte responses in elderly persons","volume":"46","author":"Talbot MC","year":"1987","journal-title":"Am J Clin Nutr"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/132.11.3308"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199207000-00007"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.18.1.23"},{"key":"e_1_2_6_8_2","first-page":"296","article-title":"Toxicity of isoniazid","volume":"68","author":"Biehl JP","year":"1953","journal-title":"Am Rev Tuberc"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-85-20891"},{"key":"e_1_2_6_10_2","first-page":"457","article-title":"The prevention and treatment of isoniazid toxicity in the therapy of pulmonary tuberculosis; 2. An assessment of the prophylactic effect of pyridoxine in low dosage","volume":"29","author":"Tuberculosis Chemotherapy Centre, Madras.","year":"1963","journal-title":"Bull Wld Hlth Org"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0041-3879(80)90038-0"},{"key":"e_1_2_6_12_2","first-page":"594","article-title":"The effect of isoniazid therapy on pyridoxine metabolism in children","volume":"75","author":"Morales SM","year":"1957","journal-title":"Rev Tuberc"},{"key":"e_1_2_6_13_2","first-page":"163","volume-title":"Tuberculosis in children","author":"Miller FJW","year":"1963"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1177\/004947559802800218"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1177\/004947550003000136"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.87.5.658"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.nutr.17.1.211"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(70)90126-0"},{"key":"e_1_2_6_19_2","volume-title":"Food composition tables","author":"South African Medical Research Council.","year":"1998"},{"key":"e_1_2_6_20_2","first-page":"119","article-title":"Comparative clinical study of protein SAP (amyloid P component) and C\u2010reactive protein in serum","volume":"32","author":"Pepys MB","year":"1978","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_6_21_2","unstructured":"Centers for Disease Control and Prevention.1994 Revised classification system for human immunodeficiency virus infection in children less than 13\u2003years of age.MMWR1994;43(RR\u201012):1\u201319."},{"key":"e_1_2_6_22_2","first-page":"153","volume-title":"Tuberculosis in childhood","author":"Donald PR","year":"1999"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.155.5.9154882"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/16.3.1215"},{"key":"e_1_2_6_25_2","first-page":"704","article-title":"Intensive short\u2010course chemotherapy in the management of tuberculous meningitis","volume":"2","author":"Donald PR","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_2_6_26_2","volume-title":"Vitamin and mineral requirements in human nutrition","author":"FAO\/WHO.","year":"2005"},{"key":"e_1_2_6_27_2","volume-title":"A language and environment for statistical computing","author":"R Development Core Team.","year":"2006"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2004.052175"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.103.23.2788"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1179\/027249302125000111"},{"key":"e_1_2_6_31_2","first-page":"593","volume-title":"Red Book: report of the committee on infectious diseases","author":"American Academy of Pediatrics.","year":"2000"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a008712"}],"container-title":["Acta Paediatrica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1651-2227.2010.01696.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1651-2227.2010.01696.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1651-2227.2010.01696.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T11:35:05Z","timestamp":1697456105000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1651-2227.2010.01696.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,29]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["10.1111\/j.1651-2227.2010.01696.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1651-2227.2010.01696.x","archive":["Portico"],"relation":{},"ISSN":["0803-5253","1651-2227"],"issn-type":[{"value":"0803-5253","type":"print"},{"value":"1651-2227","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,29]]},"assertion":[{"value":"2010-03-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}